Quest Diagnostics 4th-quarter profit falls
Jan 23 (Reuters) - Laboratory tests provider Quest Diagnostics Inc's quarterly profit fell as fewer people took tests during Superstorm Sandy in late October.
Net income fell to $140 million, or 87 cents per share, in the fourth quarter, from $184 million, or $1.16 per share, a year earlier.
Revenue from continuing operations fell 4 percent to $1.8 billion.
The No. 1 U.S. laboratory testing company cut its 2012 earnings forecast last week due to damage from superstorm Sandy and charges related to the sale of two businesses, HemoCue and OralDNA.
The company, last week, said it will restate its 2011 and 2012 results to remove the impact of HemoCue and OralDNA businesses from continuing operations.
- Female Yahoo executive sued for sexual harassment
- Gaza toll passes 100; Israel to counter rockets 'with all power' |
- Ukraine says rebels will pay as missiles kill 23 soldiers |
- U.S. Navy maintains grounding order for F-35 fighter jets
- German suspect was in contact with State Dept not U.S. spies: officials